☰

Nicolai E. Savaskan - Publications

Affiliations: 
University of Erlangen-Nurnberg, Erlangen, Bayern, Germany 
 2007-2009 Brain Research Institute Universität Zürich, Zürich, ZH, Switzerland 
 2016- Cancer & Brain BiMECON 
Area:
axon guidance, glutamate signaling, gliomas, microenvironment
Website:
www.savaskan.net
Tree Info Grants Similar researchers Related pubs Distance to... Nearest Nobel PubMed Report error

86 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Yakubov E, Ghoochani A, Savaskan N. Editorial: Ferroptosis in malignant brain tumors. Frontiers in Oncology. 13: 1276971. PMID 37841440 DOI: 10.3389/fonc.2023.1276971  0.832
2023 Yakubov E, Schmid S, Hammer A, Chen D, Dahlmanns JK, Mitrovic I, Zurabashvili L, Savaskan N, Steiner HH, Dahlmanns M. Ferroptosis and PPAR-gamma in the limelight of brain tumors and edema. Frontiers in Oncology. 13: 1176038. PMID 37554158 DOI: 10.3389/fonc.2023.1176038  0.842
2023 Dahlmanns M, Dahlmanns JK, Savaskan N, Steiner HH, Yakubov E. Glial Glutamate Transporter-Mediated Plasticity: System x/xCT/SLC7A11 and EAAT1/2 in Brain Diseases. Frontiers in Bioscience (Landmark Edition). 28: 57. PMID 37005761 DOI: 10.31083/j.fbl2803057  0.723
2021 Ackermann A, Çapcı A, Buchfelder M, Tsogoeva SB, Savaskan N. Chemical hybridization of sulfasalazine and dihydroartemisinin promotes brain tumor cell death. Scientific Reports. 11: 20766. PMID 34675351 DOI: 10.1038/s41598-021-99960-z  0.549
2021 Yakubov E, Eibl T, Hammer A, Holtmannspötter M, Savaskan N, Steiner HH. Therapeutic Potential of Selenium in Glioblastoma. Frontiers in Neuroscience. 15: 666679. PMID 34121995 DOI: 10.3389/fnins.2021.666679  0.793
2021 Reuss AM, Groos D, Buchfelder M, Savaskan N. The Acidic Brain-Glycolytic Switch in the Microenvironment of Malignant Glioma. International Journal of Molecular Sciences. 22. PMID 34073734 DOI: 10.3390/ijms22115518  0.832
2021 Reuss AM, Groos D, Ghoochani A, Buchfelder M, Savaskan N. MCT4 Promotes Tumor Malignancy in F98 Glioma Cells. Journal of Oncology. 2021: 6655529. PMID 33936203 DOI: 10.1155/2021/6655529  0.833
2017 Ackermann A, Karagöz AÇ, Ghoochani A, Buchfelder M, Eyüpoglu I, Tsogoeva SB, Savaskan N. Cytotoxic profiling of artesunic and betulinic acids and their synthetic hybrid compound on neurons and gliomas. Oncotarget. 8: 61457-61474. PMID 28977877 DOI: 10.18632/Oncotarget.18390  0.799
2017 Chen D, Rauh M, Buchfelder M, Eyupoglu IY, Savaskan N. The oxido-metabolic driver ATF4 enhances temozolamide chemo-resistance in human gliomas. Oncotarget. 8: 51164-51176. PMID 28881638 DOI: 10.18632/Oncotarget.17737  0.817
2017 Dahlmanns M, Yakubov E, Chen D, Sehm T, Rauh M, Savaskan N, Wrosch JK. Chemotherapeutic xCT inhibitors sorafenib and erastin unraveled with the synaptic optogenetic function analysis tool. Cell Death Discovery. 3: 17030. PMID 28835855 DOI: 10.1038/Cddiscovery.2017.30  0.796
2017 Fan Z, Wirth AK, Chen D, Wruck CJ, Rauh M, Buchfelder M, Savaskan N. Nrf2-Keap1 pathway promotes cell proliferation and diminishes ferroptosis. Oncogenesis. 6: e371. PMID 28805788 DOI: 10.1038/oncsis.2017.65  0.786
2017 Ackermann A, Karagöz AÇ, Ghoochani A, Buchfelder M, Eyüpoglu I, Tsogoeva SB, Savaskan N. Cytotoxic profiling of artesunic and betulinic acids and their synthetic hybrid compound on neurons and gliomas. Oncotarget. PMID 28637008 DOI: 10.18632/oncotarget.18390  0.773
2017 Chen D, Fan Z, Rauh M, Buchfelder M, Eyupoglu IY, Savaskan N. ATF4 promotes angiogenesis and neuronal cell death and confers ferroptosis in a xCT-dependent manner. Oncogene. PMID 28553953 DOI: 10.1038/Onc.2017.146  0.852
2017 Chen D, Rauh M, Buchfelder M, Eyupoglu IY, Savaskan N. The oxido-metabolic driver ATF4 enhances temozolamide chemo-resistance in human gliomas. Oncotarget. PMID 28538211 DOI: 10.18632/oncotarget.17737  0.821
2017 Chen D, Eyupoglu IY, Savaskan N. Ferroptosis and Cell Death Analysis by Flow Cytometry. Methods in Molecular Biology (Clifton, N.J.). 1601: 71-77. PMID 28470518 DOI: 10.1007/978-1-4939-6960-9_6  0.794
2016 Broggini T, Schnell L, Ghoochani A, Mateos JM, Buchfelder M, Wiendieck K, Schäfer MK, Eyupoglu IY, Savaskan NE. Plasticity Related Gene 3 (PRG3) overcomes myelin-associated growth inhibition and promotes functional recovery after spinal cord injury. Aging. 8: 2463-2487. PMID 27744421 DOI: 10.18632/aging.101066  0.801
2016 Sehm T, Rauh M, Wiendieck K, Buchfelder M, Eyüpoglu IY, Savaskan NE. Temozolomide toxicity operates in a xCT/SLC7a11 dependent manner and is fostered by ferroptosis. Oncotarget. PMID 27612422 DOI: 10.18632/Oncotarget.11858  0.839
2016 Yakubov E, Ghoochani A, Buslei R, Buchfelder M, Eyüpoglu IY, Savaskan N. Hidden association of Cowden syndrome, PTEN mutation and meningioma frequency. Oncoscience. 3: 149-55. PMID 27489861 DOI: 10.18632/oncoscience.305  0.797
2016 Xu T, Fan Z, Li W, Dietel B, Wu Y, Beckmann MW, Wrosch JK, Buchfelder M, Eyupoglu IY, Cao Z, Savaskan NE. Corrigendum: Identification of two novel Chlorotoxin derivatives CA4 and CTX-23 with chemotherapeutic and anti-angiogenic potential. Scientific Reports. 6: 26630. PMID 27220539 DOI: 10.1038/srep26630  0.762
2016 Ghoochani A, Hatipoglu Majernik G, Sehm T, Wach S, Buchfelder M, Taubert H, Eyupoglu IY, Savaskan N. Cabazitaxel operates anti-metastatic and cytotoxic via apoptosis induction and stalls brain tumor angiogenesis. Oncotarget. 7: 38306-38318. PMID 27203678 DOI: 10.18632/Oncotarget.9439  0.839
2016 Ghoochani A, Schwarz MA, Yakubov E, Engelhorn T, Doerfler A, Buchfelder M, Bucala R, Savaskan NE, Eyüpoglu IY. MIF-CD74 signaling impedes microglial M1 polarization and facilitates brain tumorigenesis. Oncogene. 35: 6246-6261. PMID 27157615 DOI: 10.1038/Onc.2016.160  0.805
2016 Sehm T, Fan Z, Ghoochani A, Rauh M, Engelhorn T, Minakaki G, Dörfler A, Klucken J, Buchfelder M, Eyüpoglu IY, Savaskan NE. Sulfasalazine impacts on ferroptotic cell death and alleviates the tumor microenvironment and glioma-induced brain edema. Oncotarget. PMID 27074570 DOI: 10.18632/Oncotarget.8651  0.839
2016 Fan Z, Bittermann-Rummel P, Yakubov E, Chen D, Broggini T, Sehm T, Hatipoglu-Majernik G, Hock SW, Schwarz M, Engelhorn T, Doerfler A, Buchfelder M, Eyupoglu IY, Savaskan NE. PRG3 induces Ras-dependent oncogenic cooperation in gliomas. Oncotarget. PMID 27058420 DOI: 10.18632/Oncotarget.8592  0.786
2016 Eyüpoglu IY, Hore N, Merkel A, Buslei R, Buchfelder M, Savaskan N. Supra‑complete surgery via dual intraoperative visualization approach (DiVA) prolongs patient survival in glioblastoma. Oncotarget. PMID 27036027 DOI: 10.18632/Oncotarget.8367  0.666
2016 Proske J, Walter L, Bumes E, Hutterer M, Vollmann-Zwerenz A, Eyüpoglu IY, Savaskan NE, Seliger C, Hau P, Uhl M. Adaptive Immune Response to and Survival Effect of Temozolomide- and Valproic Acid-induced Autophagy in Glioblastoma. Anticancer Research. 36: 899-905. PMID 26976976  0.587
2016 Xu T, Fan Z, Li W, Dietel B, Wu Y, Beckmann MW, Wrosch JK, Buchfelder M, Eyupoglu IY, Cao Z, Savaskan NE. Erratum: Identification of two novel Chlorotoxin derivatives CA4 and CTX-23 with chemotherapeutic and anti-angiogenic potential. Scientific Reports. 6: 22206. PMID 26927505 DOI: 10.1038/srep22206  0.762
2016 Xu T, Fan Z, Li W, Dietel B, Wu Y, Beckmann MW, Wrosch JK, Buchfelder M, Eyupoglu IY, Cao Z, Savaskan NE. Identification of two novel Chlorotoxin derivatives CA4 and CTX-23 with chemotherapeutic and anti-angiogenic potential. Scientific Reports. 6: 19799. PMID 26831010 DOI: 10.1038/Srep19799  0.817
2016 Eyüpoglu IY, Savaskan NE. Epigenetics in Brain Tumors: HDACs Take Center Stage. Current Neuropharmacology. 14: 48-54. PMID 26521944 DOI: 10.2174/1570159X13666151030162457  0.733
2016 Ghoochani A, Schwarz MA, Yakubov E, Engelhorn T, Doerfler A, Buchfelder M, Bucala R, Savaskan NE, Eyüpoglu IY. MIF-CD74 signaling impedes microglial M1 polarization and facilitates brain tumorigenesis Oncogene. DOI: 10.1038/onc.2016.160  0.482
2015 Ghoochani A, Yakubov E, Sehm T, Fan Z, Hock S, Buchfelder M, Eyüpoglu IY, Savaskan NE. A versatile ex vivo technique for assaying tumor angiogenesis and microglia in the brain. Oncotarget. PMID 26673818 DOI: 10.18632/Oncotarget.6550  0.818
2015 Savaskan NE, Fan Z, Broggini T, Buchfelder M, Eyupoglu IY. Neurodegeneration in the Brain Tumor Microenvironment: Glutamate in the Limelight. Current Neuropharmacology. 13: 258-65. PMID 26411769 DOI: 10.2174/1570159X13666150122224158  0.808
2015 Friedlein K, Bozhkov Y, Hore N, Merkel A, Sommer B, Brandner S, Buchfelder M, Savaskan NE, Eyüpoglu IY. A new functional classification system (FGA/B) with prognostic value for glioma patients. Scientific Reports. 5: 12373. PMID 26197301 DOI: 10.1038/Srep12373  0.803
2015 Choi J, Stradmann-Bellinghausen B, Yakubov E, Savaskan NE, Régnier-Vigouroux A. Glioblastoma cells induce differential glutamatergic gene expressions in human tumor-associated microglia/macrophages and monocyte-derived macrophages. Cancer Biology & Therapy. 16: 1205-13. PMID 26047211 DOI: 10.1080/15384047.2015.1056406  0.759
2015 Eyüpoglu IY, Hore N, Fan Z, Buslei R, Merkel A, Buchfelder M, Savaskan NE. Intraoperative vascular DIVA surgery reveals angiogenic hotspots in tumor zones of malignant gliomas. Scientific Reports. 5: 7958. PMID 25609379 DOI: 10.1038/Srep07958  0.784
2015 Hatipoglu G, Hock SW, Weiss R, Fan Z, Sehm T, Ghoochani A, Buchfelder M, Savaskan NE, Eyüpoglu IY. Sunitinib impedes brain tumor progression and reduces tumor-induced neurodegeneration in the microenvironment. Cancer Science. 106: 160-70. PMID 25458015 DOI: 10.1111/Cas.12580  0.828
2014 Wolf IM, Fan Z, Rauh M, Seufert S, Hore N, Buchfelder M, Savaskan NE, Eyüpoglu IY. Histone deacetylases inhibition by SAHA/Vorinostat normalizes the glioma microenvironment via xCT equilibration. Scientific Reports. 4: 6226. PMID 25228443 DOI: 10.1038/Srep06226  0.84
2014 Yakubov E, Buchfelder M, Eyüpoglu IY, Savaskan NE. Selenium action in neuro-oncology. Biological Trace Element Research. 161: 246-54. PMID 25164034 DOI: 10.1007/S12011-014-0111-8  0.812
2014 Sehm T, Fan Z, Weiss R, Schwarz M, Engelhorn T, Hore N, Doerfler A, Buchfelder M, Eyüpoglu IY, Savaskan NE. The impact of dietary isoflavonoids on malignant brain tumors. Cancer Medicine. 3: 865-77. PMID 24898306 DOI: 10.1002/Cam4.265  0.848
2014 Fan Z, Sehm T, Rauh M, Buchfelder M, Eyupoglu IY, Savaskan NE. Dexamethasone alleviates tumor-associated brain damage and angiogenesis. Plos One. 9: e93264. PMID 24714627 DOI: 10.1371/Journal.Pone.0093264  0.854
2013 Eyüpoglu IY, Buchfelder M, Savaskan NE. Surgical resection of malignant gliomas-role in optimizing patient outcome. Nature Reviews. Neurology. 9: 141-51. PMID 23358480 DOI: 10.1038/Nrneurol.2012.279  0.657
2012 Eyüpoglu IY, Hore N, Savaskan NE, Grummich P, Roessler K, Buchfelder M, Ganslandt O. Improving the extent of malignant glioma resection by dual intraoperative visualization approach. Plos One. 7: e44885. PMID 23049761 DOI: 10.1371/Journal.Pone.0044885  0.713
2012 Savaskan NE, Fingerle-Rowson G, Buchfelder M, Eyüpoglu IY. Brain miffed by macrophage migration inhibitory factor. International Journal of Cell Biology. 2012: 139573. PMID 22973314 DOI: 10.1155/2012/139573  0.733
2012 Vogt J, Glumm R, Schlüter L, Schmitz D, Rost BR, Streu N, Rister B, Suman Bharathi B, Gagiannis D, Hildebrandt H, Weinhold B, Mühlenhoff M, Naumann T, Savaskan NE, Brauer AU, et al. Homeostatic regulation of NCAM polysialylation is critical for correct synaptic targeting. Cellular and Molecular Life Sciences : Cmls. 69: 1179-91. PMID 22068610 DOI: 10.1007/S00018-011-0868-2  0.701
2011 Savaskan NE, Seufert S, Hauke J, Tränkle C, Eyüpoglu IY, Hahnen E. Dissection of mitogenic and neurodegenerative actions of cystine and glutamate in malignant gliomas. Oncogene. 30: 43-53. PMID 20802520 DOI: 10.1038/onc.2010.391  0.344
2011 Meier S, Bräuer AU, Heimrich B, Schwab ME, Nitsch R, Savaskan NE. Molecular analysis of Nogo expression in the hippocampus during development and following lesion and seizure (FASEB Journal (2003) 17, 9 (1153-1155) DOI: 10.1096/fj.02-0453fje) Faseb Journal. 25: 2853. DOI: 10.1096/fj.02-0453fjeRET  0.54
2010 Halstead JR, Savaskan NE, van den Bout I, Van Horck F, Hajdo-Milasinovic A, Snell M, Keune WJ, Ten Klooster JP, Hordijk PL, Divecha N. Rac controls PIP5K localisation and PtdIns(4,5)Pâ‚‚ synthesis, which modulates vinculin localisation and neurite dynamics. Journal of Cell Science. 123: 3535-46. PMID 20841379 DOI: 10.1242/Jcs.062679  0.576
2010 Savaskan NE, Eyüpoglu IY. xCT modulation in gliomas: relevance to energy metabolism and tumor microenvironment normalization. Annals of Anatomy = Anatomischer Anzeiger : Official Organ of the Anatomische Gesellschaft. 192: 309-13. PMID 20801625 DOI: 10.1016/J.Aanat.2010.07.003  0.712
2010 Broggini T, Nitsch R, Savaskan NE. Plasticity-related gene 5 (PRG5) induces filopodia and neurite growth and impedes lysophosphatidic acid- and nogo-A-mediated axonal retraction. Molecular Biology of the Cell. 21: 521-37. PMID 20032306 DOI: 10.1091/mbc.E09-06-0506  0.488
2009 Trimbuch T, Beed P, Vogt J, Schuchmann S, Maier N, Kintscher M, Breustedt J, Schuelke M, Streu N, Kieselmann O, Brunk I, Laube G, Strauss U, Battefeld A, Wende H, ... ... Savaskan NE, et al. Synaptic PRG-1 modulates excitatory transmission via lipid phosphate-mediated signaling. Cell. 138: 1222-35. PMID 19766573 DOI: 10.1016/J.Cell.2009.06.050  0.694
2009 Engelhorn T, Savaskan NE, Schwarz MA, Kreutzer J, Meyer EP, Hahnen E, Ganslandt O, Dörfler A, Nimsky C, Buchfelder M, Eyüpoglu IY. Cellular characterization of the peritumoral edema zone in malignant brain tumors. Cancer Science. 100: 1856-62. PMID 19681905 DOI: 10.1111/J.1349-7006.2009.01259.X  0.764
2009 Savaskan NE, Weinmann O, Heimrich B, Eyupoglu IY. High resolution neurochemical gold staining method for myelin in peripheral and central nervous system at the light- and electron-microscopic level. Cell and Tissue Research. 337: 213-21. PMID 19513756 DOI: 10.1007/S00441-009-0815-9  0.579
2009 Savaskan NE, Hahnen E, Eyüpoglu IY. The x(c)(-) cystine/glutamate antiporter (xCT) as a potential target for therapy of cancer: yet another cytotoxic anticancer approach? Journal of Cellular Physiology. 220: 531-2; author reply . PMID 19415694 DOI: 10.1002/Jcp.21795  0.567
2008 Savaskan NE, Heckel A, Hahnen E, Engelhorn T, Doerfler A, Ganslandt O, Nimsky C, Buchfelder M, Eyüpoglu IY. Small interfering RNA-mediated xCT silencing in gliomas inhibits neurodegeneration and alleviates brain edema. Nature Medicine. 14: 629-32. PMID 18469825 DOI: 10.1038/Nm1772  0.759
2008 Hoppe B, Bräuer AU, Kühbacher M, Savaskan NE, Behne D, Kyriakopoulos A. Biochemical analysis of selenoprotein expression in brain cell lines and in distinct brain regions. Cell and Tissue Research. 332: 403-14. PMID 18317814 DOI: 10.1007/S00441-008-0575-Y  0.713
2007 Savaskan NE, Borchert A, Bräuer AU, Kuhn H. Role for glutathione peroxidase-4 in brain development and neuronal apoptosis: specific induction of enzyme expression in reactive astrocytes following brain injury. Free Radical Biology & Medicine. 43: 191-201. PMID 17603929 DOI: 10.1016/J.Freeradbiomed.2007.03.033  0.714
2007 Dalla Puppa L, Savaskan NE, Bräuer AU, Behne D, Kyriakopoulos A. The role of selenite on microglial migration. Annals of the New York Academy of Sciences. 1096: 179-83. PMID 17405929 DOI: 10.1196/Annals.1397.084  0.696
2007 Savaskan NE, Rocha L, Kotter MR, Baer A, Lubec G, van Meeteren LA, Kishi Y, Aoki J, Moolenaar WH, Nitsch R, Bräuer AU. Autotaxin (NPP-2) in the brain: cell type-specific expression and regulation during development and after neurotrauma. Cellular and Molecular Life Sciences : Cmls. 64: 230-43. PMID 17192809 DOI: 10.1007/S00018-006-6412-0  0.721
2006 Peeva GP, Angelova SK, Guntinas-Lichius O, Streppel M, Irintchev A, Schütz U, Popratiloff A, Savaskan NE, Bräuer AU, Alvanou A, Nitsch R, Angelov DN. Improved outcome of facial nerve repair in rats is associated with enhanced regenerative response of motoneurons and augmented neocortical plasticity. The European Journal of Neuroscience. 24: 2152-62. PMID 17074041 DOI: 10.1111/J.1460-9568.2006.05091.X  0.69
2006 Eyüpoglu IY, Hahnen E, Tränkle C, Savaskan NE, Siebzehnrübl FA, Buslei R, Lemke D, Wick W, Fahlbusch R, Blümcke I. Experimental therapy of malignant gliomas using the inhibitor of histone deacetylase MS-275. Molecular Cancer Therapeutics. 5: 1248-55. PMID 16731757 DOI: 10.1158/1535-7163.Mct-05-0533  0.408
2006 Borchert A, Wang CC, Ufer C, Schiebel H, Savaskan NE, Kuhn H. The role of phospholipid hydroperoxide glutathione peroxidase isoforms in murine embryogenesis. The Journal of Biological Chemistry. 281: 19655-64. PMID 16684775 DOI: 10.1074/Jbc.M601195200  0.328
2005 Schäfer M, Bräuer AU, Savaskan NE, Rathjen FG, Brümmendorf T. Neurotractin/kilon promotes neurite outgrowth and is expressed on reactive astrocytes after entorhinal cortex lesion. Molecular and Cellular Neurosciences. 29: 580-90. PMID 15946856 DOI: 10.1016/J.Mcn.2005.04.010  0.674
2005 Eyüpoglu IY, Hahnen E, Buslei R, Siebzehnrübl FA, Savaskan NE, Lüders M, Tränkle C, Wick W, Weller M, Fahlbusch R, Blümcke I. Suberoylanilide hydroxamic acid (SAHA) has potent anti-glioma properties in vitro, ex vivo and in vivo. Journal of Neurochemistry. 93: 992-9. PMID 15857402 DOI: 10.1111/J.1471-4159.2005.03098.X  0.456
2004 Aktas O, Prozorovski T, Smorodchenko A, Savaskan NE, Lauster R, Kloetzel PM, Infante-Duarte C, Brocke S, Zipp F. Green tea epigallocatechin-3-gallate mediates T cellular NF-kappa B inhibition and exerts neuroprotection in autoimmune encephalomyelitis. Journal of Immunology (Baltimore, Md. : 1950). 173: 5794-800. PMID 15494532 DOI: 10.4049/Jimmunol.173.9.5794  0.406
2004 Schweizer U, Bräuer AU, Köhrle J, Nitsch R, Savaskan NE. Selenium and brain function: a poorly recognized liaison. Brain Research. Brain Research Reviews. 45: 164-78. PMID 15210302 DOI: 10.1016/j.brainresrev.2004.03.004  0.715
2004 Meier S, Bräuer AU, Heimrich B, Nitsch R, Savaskan NE. Myelination in the hippocampus during development and following lesion. Cellular and Molecular Life Sciences : Cmls. 61: 1082-94. PMID 15112055 DOI: 10.1007/S00018-004-3469-5  0.77
2004 Bräuer AU, Nitsch R, Savaskan NE. Identification of macrophage/microglia activation factor (MAF) associated with late endosomes/lysosomes in microglial cells. Febs Letters. 563: 41-8. PMID 15063720 DOI: 10.1016/S0014-5793(04)00244-3  0.737
2004 Bräuer AU, Savaskan NE. Molecular actions of selenium in the brain: neuroprotective mechanisms of an essential trace element. Reviews in the Neurosciences. 15: 19-32. PMID 15046197  0.682
2004 Savaskan NE, Bräuer AU, Nitsch R. Molecular cloning and expression regulation of PRG-3, a new member of the plasticity-related gene family. The European Journal of Neuroscience. 19: 212-20. PMID 14750979 DOI: 10.1046/j.1460-9568.2003.03078.x  0.74
2004 Bräuer AU, Savaskan NE, Kühn H, Prehn S, Ninnemann O, Nitsch R. Reply to 'Is PRG-1 a new lipid phosphatase?' Nature Neuroscience. 7: 789-790. DOI: 10.1038/Nn0804-789B  0.419
2003 Bräuer AU, Savaskan NE, Plaschke M, Ninnemann O, Nitsch R. Cholecystokinin expression after hippocampal deafferentiation: molecular evidence revealed by differential display-reverse transcription-polymerase chain reaction. Neuroscience. 121: 111-21. PMID 12946704 DOI: 10.1016/S0306-4522(03)00336-1  0.512
2003 Bräuer AU, Savaskan NE, Kühn H, Prehn S, Ninnemann O, Nitsch R. A new phospholipid phosphatase, PRG-1, is involved in axon growth and regenerative sprouting. Nature Neuroscience. 6: 572-8. PMID 12730698 DOI: 10.1038/nn1052  0.687
2003 Eyüpoglu IY, Savaskan NE, Bräuer AU, Nitsch R, Heimrich B. Identification of neuronal cell death in a model of degeneration in the hippocampus. Brain Research. Brain Research Protocols. 11: 1-8. PMID 12697257 DOI: 10.1016/S1385-299X(02)00186-1  0.744
2003 Meier S, Bräuer AU, Heimrich B, Schwab ME, Nitsch R, Savaskan NE. Molecular analysis of Nogo expression in the hippocampus during development and following lesion and seizure. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 17: 1153-5. PMID 12692091 DOI: 10.1096/Fj.02-0453Fje  0.793
2003 Savaskan NE, Bräuer AU, Kühbacher M, Eyüpoglu IY, Kyriakopoulos A, Ninnemann O, Behne D, Nitsch R. Selenium deficiency increases susceptibility to glutamate-induced excitotoxicity. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 17: 112-4. PMID 12424220 DOI: 10.1096/Fj.02-0067Fje  0.755
2002 Savaskan NE, Alvarez-Bolado G, Glumm R, Nitsch R, Skutella T, Heimrich B. Impaired postnatal development of hippocampal neurons and axon projections in the Emx2-/- mutants. Journal of Neurochemistry. 83: 1196-207. PMID 12437591 DOI: 10.1046/J.1471-4159.2002.01233.X  0.527
2001 Brãuer AU, Savaskan NE, Kole MH, Plaschke M, Monteggia LM, Nestler EJ, Simburger E, Deisz RA, Ninnemann O, Nitsch R. Molecular and functional analysis of hyperpolarization-activated pacemaker channels in the hippocampus after entorhinal cortex lesion. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 15: 2689-701. PMID 11726545 DOI: 10.1096/Fj.01-0235Com  0.471
2001 Savaskan NE, Nitsch R. Molecules involved in reactive sprouting in the hippocampus. Reviews in the Neurosciences. 12: 195-215. PMID 11560368 DOI: 10.1515/Revneuro.2001.12.3.195  0.466
2001 Bräuer AU, Savaskan NE, Plaschke M, Ninnemann O, Nitsch R. Perforant path lesion induces up-regulation of stathmin messenger RNA, but not SCG10 messenger RNA, in the adult rat hippocampus. Neuroscience. 102: 515-26. PMID 11226690 DOI: 10.1016/S0306-4522(00)00471-1  0.511
2000 Bräuer AU, Savaskan NE, Plaschke M, Prehn S, Ninnemann O, Nitsch R. IG-molecule Kilon shows differential expression pattern from LAMP in the developing and adult rat hippocampus. Hippocampus. 10: 632-44. PMID 11153709 DOI: 10.1002/1098-1063(2000)10:6<632::Aid-Hipo1001>3.0.Co;2-6  0.519
2000 Savaskan NE, Eyüpoglu IY, Bräuer AU, Plaschke M, Ninnemann O, Nitsch R, Skutella T. Entorhinal cortex lesion studied with the novel dye fluoro-jade. Brain Research. 864: 44-51. PMID 10793185 DOI: 10.1016/S0006-8993(00)02148-X  0.509
2000 Savaskan NE, Skutella T, Bräuer AU, Plaschke M, Ninnemann O, Nitsch R. Outgrowth-promoting molecules in the adult hippocampus after perforant path lesion. The European Journal of Neuroscience. 12: 1024-32. PMID 10762333 DOI: 10.1046/J.1460-9568.2000.00998.X  0.483
2000 Steup A, Lohrum M, Hamscho N, Savaskan NE, Ninnemann O, Nitsch R, Fujisawa H, Püschel AW, Skutella T. Sema3C and netrin-1 differentially affect axon growth in the hippocampal formation. Molecular and Cellular Neurosciences. 15: 141-55. PMID 10673323 DOI: 10.1006/Mcne.1999.0818  0.513
1999 Stein E, Savaskan NE, Ninnemann O, Nitsch R, Zhou R, Skutella T. A role for the Eph ligand ephrin-A3 in entorhino-hippocampal axon targeting. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 19: 8885-93. PMID 10516308 DOI: 10.1523/Jneurosci.19-20-08885.1999  0.488
1999 Skutella T, Savaskan NE, Ninnemann O, Nitsch R. Target- and maturation-specific membrane-associated molecules determine the ingrowth of entorhinal fibers into the hippocampus. Developmental Biology. 211: 277-92. PMID 10395788 DOI: 10.1006/Dbio.1999.9295  0.478
1999 Steup A, Ninnemann O, Savaskan NE, Nitsch R, Püschel AW, Skutella T. Semaphorin D acts as a repulsive factor for entorhinal and hippocampal neurons. The European Journal of Neuroscience. 11: 729-34. PMID 10051774 DOI: 10.1046/J.1460-9568.1999.00517.X  0.482
1999 Savaskan NE, Plaschke M, Ninnemann O, Spillmann AA, Schwab ME, Nitsch R, Skutella T. Myelin does not influence the choice behaviour of entorhinal axons but strongly inhibits their outgrowth length in vitro. The European Journal of Neuroscience. 11: 316-26. PMID 9987034 DOI: 10.1046/J.1460-9568.1999.00430.X  0.594
Show low-probability matches.